CD70 and glioblastoma: We also found that only 6 out of 59 (10%) of brain cancer cases were CD70+, whereas Wischhusen et al (2002) found that 5 out of 12 of glioblastomas and 3 out of 4 anaplastic astrocytomas were positive for CD70 protein.